Futura Medical erection-enhancing condom gets EU recommendation
CSD500 incorporates an erectogenic compound to help men maintain a firmer erection during intercourse whilst wearing a condom. The CE mark would enable the condom to be sold
Amgen has received a positive opinion from the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) for Repatha (evolocumab) supporting its broader use prior to a first heart attack or stroke.
The partnership also involves TransPerfect’s Trial Interactive Portal Technology, which is already being used by biopharmaceutical firms for electronic Trial Master Files, investigator portals, IRB and central laboratory